EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus
EUFOREA (The European Forum for Research and Education in Allergy and Airways diseases) organised its bi-annual forum called EUFOREUM in Berlin in November 2023 aiming to highlight paediatric action plans for prevention and optimising care for type 2 inflammatory conditions starting in childhood, focusing on the early-stage diagnosis, ensuring neither under- nor overdiagnosis, optimal care, and suggestions for improvement of care. EUFOREA is an international non-profit organisation allying all stakeholders dedicated to reducing the prevalence and burden of chronic respiratory diseases through implementing optimal patient care via educational, research, and advocacy activities.
The inclusive and multidisciplinary approach of EUFOREA was reflected in the keynote lectures and faculty of the virtual EUFOREUM 2023 (www.euforea.eu/euforeum) coming from the paediatric, allergology, pulmonology, ENT, dermatology, primary health care fields and patients around the central theme of type 2 inflammation. As most type 2 inflammatory conditions may start in childhood or adolescence, and most children have type 2 inflammation when suffering from a respiratory or skin disease, the moment has come to raise the bar of ambitions of care, including prevention, remission and disease modification at an early stage.
The current report provides a comprehensive overview of key statements by the faculty of the EUFOREUM 2023 and the ambitions of EUFOREA allowing all stakeholders in the respiratory field to be updated and ready to join forces in Europe and beyond.
Co-Authors: Diego M Conti, Backer Vibeke, Beyer Kirsten, Bjermer Leif, Chaker Adam, Dramburg Stephanie, Gaga Mina, Gappa Monika, Gevaert Philippe, Hamelmann Eckard, Peter W Hellings, Jesenak Milos, Matthias V Kopp, Maurer Marcus, Podesta Marcia, Ryan Dermot, Glenis Scadding, Wüstenberg Eike, Wahn Ulrich, Lau Susanne